Nicholas C.H. Roper is a member of the firm’s capital markets and mergers & acquisitions groups. Nick focuses his practice on representing public companies, investment banks and private equity firms and their portfolio companies in connection with capital markets transactions as well as mergers & acquisitions and other strategic transactions. He also regulatory advises clients on a wide range of securities law and corporate governance issues.
Prior to joining Ropes & Gray, Nick practiced law at a leading law firm in New York.
Prior to law school, Nick worked for the Boston Red Sox Baseball Club.
Experience
Capital markets matters include representing:
- Olaplex Holdings, a hair care company, and sponsor Advent International, in the company's $1.8 billion initial public offering.
- RallyBio Corporation in its approximately $81 million IPO.
- Hayward Holdings, a maker of pool equipment and chemicals, and the selling shareholders in the company's $685 million initial public offering and $348 million follow-on offering.
- the lead underwriters in approximately $250 million IPO for Cullinan Oncology.
- the lead underwriters in approximately $600 million IPO and approximately $1.3 billion registered follow-on offering for Moderna.
- Ironwood Pharmaceuticals in $330 million offering of senior convertible notes.
- TransMedics Group, a medical technology company focused on transforming organ transplant therapy for end-stage organ failure patients, in its approximately $105 million IPO and approximately $70 million registered follow-on offering.
- Skyline Champion Corporation and the selling shareholders in follow-on offerings
- Ambac Assurance Corporation, a Wisconsin domiciled insurance company, in a holistic restructuring transaction that involved three exchange offers of existing debt securities and other payment obligations for approximately $2.2 billion of newly-issued debt securities, as well as a new-money financing collateralized by the future proceeds of certain litigation claims against RMBS originators.*
- the lead underwriters in the $300 million offering of 3.700% senior notes due 2025 by RenaissanceRe Finance.*
- the lead underwriters in the $169 million initial public offering of GMS.*
- Univar in its $855 million initial public offering and concurrent private placement of $350 million of shares to Temasek and the additional purchase of 5 million shares of Univar common stock from selling stockholders by Temasek.*
HD Supply in its $1.25 billion offering of 5.25% senior secured first priority notes due 2021.*
Mergers & acquisitions matters include representing:
- CIRCOR International in its $1.6 billion sale to KKR.
- Provention Bio in its $2.9 billion sale to Sanofi.
- Dragoneer Growth Opportunities Corp., a special purpose acquisition company, in its approximately $7 billion business combination with CCC Information Services.
- Wright Medical N.V. in its $5.4 billion sale to Stryker.
- Advent in revised transaction to acquire Forescout Technologies.
- Teradyne Inc. in its acquisition of AutoGuide Mobile Robots.
- International Paper on the $1.8 billion combination of its North America Consumer Packaging Business with Graphic Packaging.*
*Representations completed prior to joining Ropes & Gray.